Wellness company Ombre recently emerged with a new identity, announcing new leadership, seed funding and a complete rebrand.
The company is now led by CEO Elise Contarsy, a consumer product branding and merchandising expert. Contarsy said the overhaul gives the brand extra room for expansion to serve more customers in different ways in the personalized health sphere.
“We changed our name and identity to better reflect the company we are building—one that reflects the concept of the quantified self. As consumers evolve and embrace personalized data, services, and health products, our brand has grown. We are not just changing our name; we are also improving our products and services, including our home tests, gut health reports, and in-app experience. While our name and brand identity will change, we will continue with the same DNA analysis process of consumer home testing kits,” Contarsy told NutraIngredients-USA.
New identity, new funds
Ombre has raised $3 million in a seed round, led by PivotNorth Capital, with participation from Trail Mix Ventures, Shanda Group, Unilever Ventures, Social Starts’ fund Joyance Partners, and Unpopular Ventures. This seed round brings the company’s total funds raised to $9.5 Million.
The fresh funds will go toward Ombre’s evolution, which include improvements to their products, supply chain, and services, such as their home tests, gut health reports, probiotic formulations, and in-app experience.
Probiotic formulations
“Our new probiotic formulations will provide our customers access to the latest in probiotic strain research to support their wellness goals. Our new proprietary probiotic formulations contain clinically-supported strains proven to target specific symptoms as well as general health. In modulating the gut biome with researched-backed strains, our probiotic design targets microbial imbalances while encouraging the growth of beneficial bacteria that contribute to overall wellness.”